Companies also announce five-year distribution agreement for advanced technology that reduces need for allogeneic blood transfusions LAKE ZURICH, Ill. & ANN ARBOR, Mich.--(BUSINESS WIRE)--Fresenius ...

LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, today announced its innovative autotransfusion system (ATS), XTRA ®, has ...

Rockville, Feb. 10, 2023 (GLOBE NEWSWIRE) -- The global autotransfusion systems market is valued at US$ 315.4 million in 2023 and is predicted to expand at a CAGR of 4% from 2023 to 2033, as per this ...

Haemonetics HAE recently gained FDA’s 510(k) clearance for its next-generation Intelligent Control Software for Cell Saver Elite+ Autotransfusion System. The approval was followed by a full market ...

BOSTON, March 2, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, has ...

Rapid technological advancements in the autotransfusion system, rise in prevalence of cardiovascular disease, and increasing adoption of autotransfusion systems are estimated the propel the growth of ...

The market report is a good combination of qualitative and quantitative data that highlights significant market changes, obstacles that business and the competition must overcome, as well as new ...